A 6-wk, double-blinded, placebo-controlled study was done to ascertain the
effects of pyruvate supplementation (6 g/d) on body weight, body compositio
n, and Vigor and fatigue levels in healthy overweight Caucasian men and wom
en. Twenty-six individuals were randomly assigned to a placebo group (seven
men, seven women) and a pyruvate-supplemented group (three men, nine women
). In addition, all subjects participated in a 3 d/wk exercise program, whi
ch consisted of a 45-60 min aerobic/anaerobic routine. After 6 wk of treatm
ent, there was a statistically significant decrease in body weight (-1.2 kg
, P < 0.001), body fat (-2.5 kg, P < 0.001), and percent body fat (23.0% pr
e versus 20.3% 6 wk post) in the pyruvate group. Furthermore, Profile of Mo
od States fatigue and vigor scores improved significantly for the pyruvate
group (P < 0.05) at 6 wk (vigor) and 4 and 6 wk (fatigue). There was no sig
nificant change in total lean body mass in the pyruvate group. The placebo
group demonstrated a significant increase (P < 0.05) for POMS vigor at 2 an
d 4 wk with no changes occurring in any of the remaining parameters measure
d. Thus, the ingestion of 6 g of pyruvate for 6 wk, in conjunction with mil
d physical activity, resulted in a significant decrease in body weight and
fat mass. (C) Elsevier Science Inc. 1999.